Antibody Persistence at Age 3.5 and 4.5 Years After Primary and Booster DTaP-IPV-Hep B-PRP~T or Infanrix Hexa Vaccination

Clinical trial NCT01983540 · COMPLETED

Trial details

NCT number: NCT01983540
Sponsor: Sanofi Pasteur, a Sanofi Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diphtheria Tetanus Whooping Cough Hepatitis B Poliomyelitis Haemophilus Influenzae Type b

Start date: 2013-10-01
Primary completion: 2015-06-01
Enrollment: 558

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.